- Home
- SCD vs EBS Comparison
SCD vs EBS Comparison
Compare SCD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCD | EBS |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.2M | 413.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | SCD | EBS |
|---|---|---|
| Price | $15.58 | $8.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 49.2K | ★ 930.3K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 9.63% | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $118.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.79 | $5.62 |
| 52 Week High | $16.18 | $14.06 |
Technical Indicators
Market Signals| Indicator | SCD | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 54.27 | 49.90 |
| Support Level | $15.39 | $7.77 |
| Resistance Level | $15.80 | $8.54 |
| Average True Range (ATR) | 0.23 | 0.42 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 53.97 | 66.67 |
Price Performance
Historical ComparisonAbout SCD LMP Capital and Income Fund Inc.
Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.